The relation between cartilage biomarkers (C2C,C1,2C,CS846, and CPII) and the long-term outcome of rheumatoid arthritis patients within the CAMERA trial |
| |
| Authors: | Marije F Bakker Suzanne MM Verstappen Paco MJ Welsing Johannes WG Jacobs Zalima N Jahangier Maaike J van der Veen Johannes WJ Bijlsma Floris PJG Lafeber the Utrecht Arthritis Cohort study group |
| |
| Institution: | (1) Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands;(2) Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands;(3) Department of Rheumatology, Tergooi Hospital, P.O. Box 10016, 1201 DA Hilversum, The Netherlands;(4) Department of Rheumatology, St. Jansdal Hospital, P.O. Box 138, 3840 AC Harderwijk, The Netherlands |
| |
| Abstract: | Introduction The aim of this study was to investigate whether serum biomarker levels of C2C, C1,2C, CS846, and CPII can predict the long-term
course of disease activity and radiographic progression early in the disease course of rheumatoid arthritis (RA). |
| |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
|
